NO905215D0 - Fremgangsmaate til fremstilling av 4-substituerte alkylkarbapenemforbindelser. - Google Patents

Fremgangsmaate til fremstilling av 4-substituerte alkylkarbapenemforbindelser.

Info

Publication number
NO905215D0
NO905215D0 NO1990905215A NO905215A NO905215D0 NO 905215 D0 NO905215 D0 NO 905215D0 NO 1990905215 A NO1990905215 A NO 1990905215A NO 905215 A NO905215 A NO 905215A NO 905215 D0 NO905215 D0 NO 905215D0
Authority
NO
Norway
Prior art keywords
alkycular
substituted
procedure
preparation
carbon compounds
Prior art date
Application number
NO1990905215A
Other languages
English (en)
Other versions
NO905215L (no
NO177640C (no
NO177640B (no
Inventor
Alain Martel
Carol Bachand
Marcel Menard
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO905215D0 publication Critical patent/NO905215D0/no
Publication of NO905215L publication Critical patent/NO905215L/no
Publication of NO177640B publication Critical patent/NO177640B/no
Publication of NO177640C publication Critical patent/NO177640C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO905215A 1989-12-04 1990-12-03 Analogifremgangsmåte til fremstilling av terapeutisk aktive 4-substituerte alkylkarbapenemforbindelser NO177640C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44601789A 1989-12-04 1989-12-04
US61392190A 1990-11-20 1990-11-20

Publications (4)

Publication Number Publication Date
NO905215D0 true NO905215D0 (no) 1990-12-03
NO905215L NO905215L (no) 1991-06-05
NO177640B NO177640B (no) 1995-07-17
NO177640C NO177640C (no) 1995-10-25

Family

ID=27034476

Family Applications (1)

Application Number Title Priority Date Filing Date
NO905215A NO177640C (no) 1989-12-04 1990-12-03 Analogifremgangsmåte til fremstilling av terapeutisk aktive 4-substituerte alkylkarbapenemforbindelser

Country Status (13)

Country Link
EP (1) EP0433759A1 (no)
KR (1) KR910011856A (no)
AU (2) AU643735B2 (no)
CA (1) CA2031487A1 (no)
FI (1) FI96311C (no)
HU (1) HU213265B (no)
IE (1) IE904348A1 (no)
IL (1) IL96528A (no)
NO (1) NO177640C (no)
NZ (1) NZ236319A (no)
OA (1) OA09333A (no)
PT (1) PT96080B (no)
YU (1) YU229290A (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5672701A (en) * 1990-01-16 1997-09-30 Bristol-Myers Squibb Company 4-substituted alkyl carbapenem antibiotics
US5317016A (en) * 1991-08-20 1994-05-31 Shionogi Seiyaku Kabushiki Kaisha Pyrrolidylthiocarbapenem derivative
NO20015844L (no) 2001-11-30 2003-06-02 Arne Kristiansen Anordning for å produsere et trykkpotensial over et legeme
MX355728B (es) 2011-05-17 2018-04-27 Univ California Inhibidores de cinasas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4312871A (en) * 1979-12-03 1982-01-26 Merck & Co., Inc. 6-, 1- And 2-substituted-1-carbadethiapen-2-em-3-carboxylic acids
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd 1―置換カルバペネム―3―カルボン酸誘導体
CA1272719A (en) * 1986-03-06 1990-08-14 Pierre Dextraze Carbapenem antibiotics
US4960879A (en) * 1988-03-23 1990-10-02 Shionogi & Co., Ltd. Process for carbapenem intermediates
US5189158A (en) * 1991-03-20 1993-02-23 American Cyanamid Company 4-substituted azetidinones as precursors to 2-substituted-3-carboxy carbapenem antibiotics and a method of producing them

Also Published As

Publication number Publication date
OA09333A (fr) 1992-09-15
AU661192B2 (en) 1995-07-13
FI905912A (fi) 1991-06-05
KR910011856A (ko) 1991-08-07
PT96080B (pt) 1998-02-27
FI905912A0 (fi) 1990-11-30
CA2031487A1 (en) 1991-06-05
NO905215L (no) 1991-06-05
YU229290A (sh) 1993-05-28
EP0433759A1 (en) 1991-06-26
IE904348A1 (en) 1991-06-05
IL96528A (en) 1996-06-18
AU643735B2 (en) 1993-11-25
PT96080A (pt) 1991-09-30
FI96311B (fi) 1996-02-29
NZ236319A (en) 1994-02-25
AU4611793A (en) 1993-12-02
HU213265B (en) 1997-04-28
HU908046D0 (en) 1991-06-28
FI96311C (fi) 1996-06-10
HUT56371A (en) 1991-08-28
AU6768890A (en) 1991-06-06
NO177640C (no) 1995-10-25
NO177640B (no) 1995-07-17

Similar Documents

Publication Publication Date Title
NO900830D0 (no) Fremgangsmaate for fremstilling av piperidinforbindelser.
NO905255L (no) Fremgangsmaate for fremstilling av heterocyklisk substituerte acylaminotiazoler.
NO905008D0 (no) Fremgangsmaate for fremstilling av heterocykliske forbindelser.
NO890269D0 (no) Fremgangsmaate for fremstilling av 1,4-disubstituerte-piperidinyl-forbindelser.
NO900934D0 (no) Fremgangsmaate for fremstilling av 4-substituerte piperaziner.
NO895067D0 (no) Fremgangsmaate til fremstilling av derivater av alfa, d-glukofuranose.
NO861486L (no) Fremgangsmaate til fremstilling av fluorerte benzyltriazolforbindelser.
NO904285L (no) Fremgangsmaate for fremstilling av substituerte karboksytetrahydroisokinoliner.
NO892204D0 (no) Fremgangsmaate for fremstilling av imidazokinoxalin-forbindelser.
NO905444L (no) Fremgangsmaate til fremstilling av oksazolderivater.
NO901690D0 (no) Fremgangsmaate til fremstilling av substituerte azetidinylisotiazolpyridon-derivater.
NO167807C (no) Analogifremgangsmaate til fremstilling av 3',4'-dinitrogensubstituerte epipodofyllotoksinglukosidderivater.
NO883145D0 (no) Fremgangsmaate til fremstilling av tienoimidazolderivater.
NO905215L (no) Fremgangsmaate til fremstilling av 4-substituerte alkylkarbapenemforbindelser.
NO903666L (no) Fremgangsmaate for fremstilling av pyrrolokinolinforbindelser.
NO901067L (no) Fremgangsmaate for fremstilling av tiofener.
NO904535D0 (no) Fremgangsmaate for fremstilling av fenoxy-heterocykliske forbindelser.
NO904060L (no) Fremgangsmaate for fremstilling av substituerte dibenzofuraner.
NO900969L (no) Fremgangsmaate for fremstilling av n-allymetatrifluormetylanilin.
NO874617D0 (no) Fremgangsmaate til fremstilling av 2,6-diamino-3-halogenobenzylpyridiner.
NO883610L (no) Fremgangsmaate til fremstilling av substituerte tienoimidazol-derivater.
NO880106D0 (no) Fremgangsmaate til fremstilling av kalknitrogen.
NO913089L (no) Fremgangsmaate for fremstilling av tetrazolforbindelser.
NO874548D0 (no) Fremgangsmaate for fremstilling av piperidinforbindelser.
NO891004L (no) Fremgangsmaate til fremstilling av 7-oksomitosan-derivater.